amivantamab
janssen
['lcsm,(-blcsm)', 'amivantamab', 'biomarker']
presentation by regarding biomarkers of response to amivantamab. for such a hard drug to tolerate, identification of the patients who would benefit the most makes a lot of sense. #asco23 #lcsm
Husband, Father.
Medical Oncologist and Researcher focused in Thoracic Oncology.
Views are my own.